Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma
Malignant pleural mesothelioma (MPM) is an invasive malignancy that develops in the pleural cavity, and antifolates are used as chemotherapeutics for treating. The majority of antifolates, including pemetrexed (PMX), inhibit enzymes involved in purine and pyrimidine synthesis. MPM patients frequentl...
Saved in:
Main Authors: | Yuzo Sato (Author), Masaru Tomita (Author), Tomoyoshi Soga (Author), Atsushi Ochiai (Author), Hideki Makinoshima (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells
by: Yuzo Sato, et al.
Published: (2018) -
Molecular signaling mechanisms that mediate exercise training effects on insulin sensitivity
by: Masaru Nagasaki, et al.
Published: (2013) -
Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
by: Ranjit K Goudar
Published: (2008) -
Dramatic increase in glycerol biosynthesis upon oxidative stress in the anaerobic protozoan parasite Entamoeba histolytica.
by: Afzal Husain, et al.
Published: (2012) -
Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
by: Sharareh Seifi, et al.
Published: (2023)